Sarcoma Care Practice in India During COVID Pandemic: A Nationwide Survey.

COVID19 India PPE Sarcoma Survey

Journal

Indian journal of orthopaedics
ISSN: 0019-5413
Titre abrégé: Indian J Orthop
Pays: Switzerland
ID NLM: 0137736

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 03 06 2020
accepted: 17 07 2020
pubmed: 25 8 2020
medline: 25 8 2020
entrez: 25 8 2020
Statut: epublish

Résumé

Amidst the COVID-19 pandemic, management of cancer has been one of the most intensely debated topics across the globe. We conducted an online survey to determine the consistency/or the lack of it, in the management of sarcoma patients between centres and the changes in policies. A twenty-five question online survey was conducted among practicing physicians over a period of 10 days using online portal (surveymonkey.com). It was followed by a critical analysis based on responses to each question. Of 194 medical professionals who participated, 80% were surgeons and 53% were working in government institutes. Most respondents (81%) continued their practice with some modifications. In OP majority (67%) relied only on symptom, contact enquiry and temperature recording for screening. COVID-19 testing was done more (43%) in IP patients. Most of institutes (83%) followed rotational policy to reduce the number of staff at risk while 57% offered an alternate accommodation. 52.3% continued chemotherapy for all patients while radiotherapy for all was offered by 45%. In metastatic cases, majority preferred either no treatment or non-surgical intervention (71%).84.5% believed in adapting changes (42%-avoid supra major surgeries, 27%-Operating only emergency cases and 15.5%-High grade sarcomas with curative intent) in surgical management of sarcomas. For benign bone tumors, majority (71%) agreed on adapting changes while 25% agreed on deferring all cases. 69% preferred teleconsultations for follow-up. Complete PPE were being used for all aerosol generating procedures by 44%. Only two thirds agreed with their institutes policy of PPE usage and COVID-19 testing. This survey has highlighted disparity on COVID-19 screening and management in various institutes across the country. This will act as a reference point for tracking future trends in bone and soft tissue tumor management guidelines, as the COVID-19 scenario unfolds globally and particularly in India.

Sections du résumé

BACKGROUND BACKGROUND
Amidst the COVID-19 pandemic, management of cancer has been one of the most intensely debated topics across the globe. We conducted an online survey to determine the consistency/or the lack of it, in the management of sarcoma patients between centres and the changes in policies.
METHODS METHODS
A twenty-five question online survey was conducted among practicing physicians over a period of 10 days using online portal (surveymonkey.com). It was followed by a critical analysis based on responses to each question.
RESULTS RESULTS
Of 194 medical professionals who participated, 80% were surgeons and 53% were working in government institutes. Most respondents (81%) continued their practice with some modifications. In OP majority (67%) relied only on symptom, contact enquiry and temperature recording for screening. COVID-19 testing was done more (43%) in IP patients. Most of institutes (83%) followed rotational policy to reduce the number of staff at risk while 57% offered an alternate accommodation. 52.3% continued chemotherapy for all patients while radiotherapy for all was offered by 45%. In metastatic cases, majority preferred either no treatment or non-surgical intervention (71%).84.5% believed in adapting changes (42%-avoid supra major surgeries, 27%-Operating only emergency cases and 15.5%-High grade sarcomas with curative intent) in surgical management of sarcomas. For benign bone tumors, majority (71%) agreed on adapting changes while 25% agreed on deferring all cases. 69% preferred teleconsultations for follow-up. Complete PPE were being used for all aerosol generating procedures by 44%. Only two thirds agreed with their institutes policy of PPE usage and COVID-19 testing.
CONCLUSION CONCLUSIONS
This survey has highlighted disparity on COVID-19 screening and management in various institutes across the country. This will act as a reference point for tracking future trends in bone and soft tissue tumor management guidelines, as the COVID-19 scenario unfolds globally and particularly in India.

Identifiants

pubmed: 32836364
doi: 10.1007/s43465-020-00206-3
pii: 206
pmc: PMC7393016
doi:

Types de publication

Journal Article

Langues

eng

Pagination

350-357

Informations de copyright

© Indian Orthopaedics Association 2020.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declare that they have no conflict of interest.

Auteurs

Ashish Gulia (A)

Dept of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.

Akshay Tiwari (A)

Musculoskeletal Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.

Ramandeep Singh Arora (RS)

Paediatric Oncology, Max Super Speciality Hospital, New Delhi, India.

Srinath Gupta (S)

Dept of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.

Anand Raja (A)

Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India.

Classifications MeSH